Standout Papers

Prevalence of and Risk Factors for Diabetic Macular Edema in the United States 2014 2026 2018 2022 279
  1. Prevalence of and Risk Factors for Diabetic Macular Edema in the United States (2014)
    Rohit Varma, Neil M. Bressler et al. JAMA Ophthalmology
  2. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial (2021)
    John A. Spertus, Jennifer Fine et al. The Lancet

Immediate Impact

2 from Science/Nature 83 standout
Sub-graph 1 of 22

Citing Papers

Gene Editing for CEP290 -Associated Retinal Degeneration
2024 Standout
Age-related macular degeneration
2023 Standout
12 intermediate papers

Works of Chantal Dolan being referenced

Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment
2014
Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization
2011
and 12 more

Author Peers

Author Last Decade Papers Cites
Chantal Dolan 1067 851 262 381 37 1.8k
B.C.P. Polak 1301 977 202 114 60 2.1k
Shoshana Colman 743 589 338 112 21 1.9k
C Alex Harper 1625 1136 245 108 66 2.3k
Lawrence I. Rand 601 492 195 280 34 2.6k
Sophie Rogers 2349 1621 183 108 49 2.9k
Ava Grace Tan 1396 1101 381 83 61 2.0k
Jessica N. Cooke Bailey 481 304 247 89 63 1.7k
John G. Walt 1495 811 380 55 55 2.3k
David Maberley 1864 1345 235 55 99 2.4k
Joanne Wu 1129 734 596 51 58 1.8k

All Works

Loading papers...

Rankless by CCL
2026